Literature DB >> 1448826

Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group.

D H O'Leary1, J F Polak, R A Kronmal, S J Kittner, M G Bond, S K Wolfson, W Bommer, T R Price, J M Gardin, P J Savage.   

Abstract

BACKGROUND AND
PURPOSE: This article describes the prevalence of extracranial carotid atherosclerosis assessed by ultrasonography, its association with risk factors, and its relation to symptomatic coronary disease and stroke in men and women aged > or = 65 years.
METHODS: Maximum percent stenosis, maximum common carotid artery wall thickness, and maximum internal carotid artery wall thickness were assessed using duplex ultrasound in 5,201 men and women aged > or = 65 years in the Cardiovascular Health Study, a study of the risk factors and natural history of cardiovascular disease in the elderly. Existing coronary disease and stroke were assessed by physical examination and participant history.
RESULTS: Detectable carotid stenosis was present in 75% of men and 62% of women, although the prevalence of > or = 50% stenosis was low, 7% in men and 5% in women. Maximum stenosis and maximum wall thickness measurements increased with age and were uniformly greater at all ages in men than in women (p < 0.00001). Established risk factors for atherosclerosis (hypertension, smoking, diabetes) and indications of vascular disease (left ventricular hypertrophy, major electrocardiographic abnormality, bruits, and history of heart disease or stroke) related to all three carotid artery measures in the elderly. Of the three ultrasound measures, the best correlate for a history of coronary disease was maximum internal carotid artery wall thickness. For stroke the best correlate was common carotid artery wall thickness. Multiple logistic regression models of prevalent coronary heart disease and stroke that included the ultrasound findings indicated, after adjustment for age and sex, that maximum internal wall thickness and maximum common carotid wall thickness were significant correlates of both. Maximum stenosis did not add significantly to the correlation.
CONCLUSIONS: In the elderly the incidence of carotid atherosclerosis was high, although the frequency of severe disease was low. The prevalence and severity of carotid atherosclerosis continued to increase with age even in the late decades of life, and more disease was found in men than in women at all ages. Known risk factors for atherosclerosis continued to relate to carotid abnormalities in the later decades of life, both in symptomatic and asymptomatic subjects.

Entities:  

Mesh:

Year:  1992        PMID: 1448826     DOI: 10.1161/01.str.23.12.1752

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  145 in total

Review 1.  Nuclear cardiology approaches to defining normal and abnormal cardiovascular aging.

Authors:  J L Fleg; S P Schulman
Journal:  J Nucl Cardiol       Date:  1999 Sep-Oct       Impact factor: 5.952

Review 2.  The antiatherogenic effects of antihypertensive treatment: trials completed and ongoing.

Authors:  A Zanchetti
Journal:  Curr Hypertens Rep       Date:  2001-08       Impact factor: 5.369

Review 3.  Association of physical activity level and stroke outcomes in men and women: a meta-analysis.

Authors:  Lien Diep; John Kwagyan; Joseph Kurantsin-Mills; Roger Weir; Annapurni Jayam-Trouth
Journal:  J Womens Health (Larchmt)       Date:  2010-10       Impact factor: 2.681

4.  Genetic and environmental contributions to carotid intima-media thickness and obesity phenotypes in the Northern Manhattan Family Study.

Authors:  Suh-Hang Hank Juo; Hsiu-Fen Lin; Tanja Rundek; Edison A Sabala; Bernadette Boden-Albala; Naeun Park; Min-Yu Lan; Ralph L Sacco
Journal:  Stroke       Date:  2004-08-26       Impact factor: 7.914

5.  Use of carotid intima-media thickness regression to guide therapy and management of cardiac risks.

Authors:  P Costanzo; J G Cleland; S L Atkin; E Vassallo; P Perrone-Filardi
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-02

6.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-12-15       Impact factor: 29.690

7.  Aggregation of vascular risk factors and risk of incident Alzheimer disease.

Authors:  J A Luchsinger; C Reitz; L S Honig; M X Tang; Steven Shea; R Mayeux
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

8.  Impaired Cerebral Hemodynamics and Cognitive Performance in Patients with Atherothrombotic Disease.

Authors:  Salo Haratz; Galit Weinstein; Noa Molshazki; Michal Schnaider Beeri; Ramit Ravona-Springer; Oleg Marzeliak; Uri Goldbourt; David Tanne
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 9.  Abnormalities of vascular structure and function in pediatric hypertension.

Authors:  Elaine M Urbina
Journal:  Pediatr Nephrol       Date:  2015-08-15       Impact factor: 3.714

10.  Echocardiographic left ventricular mass index predicts incident stroke in African Americans: Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Ervin R Fox; Nabhan Alnabhan; Alan D Penman; Kenneth R Butler; Herman A Taylor; Thomas N Skelton; Thomas H Mosley
Journal:  Stroke       Date:  2007-08-30       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.